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Abstract: 
Linking gene and protein names mentioned in the literature to unique identifiers in referent genomic databases is 
an essential step in accessing and integrating knowledge in the biomedical domain. However, it remains a 
challenging task due to lexical and terminological variation, and ambiguity of gene name mentions in documents. 
We present a generic and effective rule-based approach to link gene mentions in the literature to referent genomic 
databases, where pre-processing of both gene synonyms in the databases and gene mentions in text are first applied. 
The mapping method employs a cascaded approach, which combines exact, exact-like and token-based 
approximate matching by using flexible representations of a gene synonym dictionary and gene mentions 
generated during the pre-processing phase. We also consider multi-gene name mentions and permutation of 
components in gene names. A systematic evaluation of the suggested methods has identified steps that are 
beneficial for improving either precision or recall in gene name identification. The results of the experiments on 
the BioCreAtIvE2 data sets (identification of human gene names) demonstrated that our methods achieved highly 
encouraging results with F-measure of up to 81.20%. 
 
Keywords: gene name normalisation; gene name mapping; lexical variability; text mining 
 
Background: 
Finding, integrating and exploiting information on genes 
and proteins they encode is an essential task in the 
biomedical domain. Automated identification of gene 
and protein names in biomedical text is therefore a 
fundamental step in biomedical text mining. [1, 2] For 
example, the identification of both protein names that act 
as transcription factors and corresponding target genes is 
the first step in a semi-automated construction of 
regulatory networks from the literature. Gene/protein 
name identification refers to the process of linking a 
mention of a name in text to a relevant entry in a 
genomic database (e.g. Entrez Gene [3], or UniProt [4]). 
However, due to the high level of variations, 
irregularities and ambiguity of the employed gene name 
nomenclatures associated with individual organisms, 
gene and protein identification remains a challenging 
task. [1, 5, 6] The problem is also magnified by authors 
using additional, non-standard “free” forms to refer to 
genes in the literature, and through ambiguity of gene 
names across different species. 
 
The task of gene identification is generally addressed 
through a two-step process. The first step deals with the 
recognition of gene or protein mentions in text (gene 
mention identification). The aim here is to recognise 
strings that correspond to gene names. The second step 
provides a mapping of the detected mentions to 
standardised gene identifiers (gene name normalisation 
or mapping). It aims at generating a list of unique 
identifiers (typically from a referent genomic database) 
for each of the gene and protein mentions. The 
normalisation aids in treating different mentions 
associated with the same entity as equivalent, which is 
essential for information access and integration.  
 
In this paper we focus on gene name normalisation. A 
gene candidate mention list can be produced by a gene 
tagger (e.g. [7]), and then each identified mention is to 
be assigned with a normalised unique gene identifier. 
Several approaches have been undertaken over recent 
years to provide solutions for gene name normalisation. 
[8] Dictionary-based methods have used existing 
terminological resources and various string matching 
approaches to locate gene mentions in text, and thus 
perform both tasks simultaneously (linking textual 
strings to matching database entries). Due to variability 
and ambiguity of gene names, simple pattern matching 
typically results in low precision and moderate recall (e.g. 
Hirschman et. al [5] have reported extremely low 
precision rate (2% for full articles and 7% for abstracts) 
with recall in the range 31% (for abstracts) to 84% (for 
full articles) when using FlyBase). These approaches are 
generally enhanced with additional rule- and token-class 
based techniques, while distinguishing between 
important and less important constituents. [6, 9, 10] For 
example, Prominer [11] uses a gene dictionary that 
includes various spelling variants to support gene  name 
matching, including an approximate matching procedure 
in which it treats each (candidate) string as a sequence of 
tokens, which are assigned to corresponding classes (e.g. 
measurement, digit, modifier, etc.). The classes are then 
used to weight mismatches in the approximate matching 
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(e.g. the mismatch weight for the modifier class (which 
includes tokens such as receptor, precursor) is high). 
Similarly, Tamames [6] tags every token in a document 
with a set of gene-relevant categories (e.g. core, 
chemical, type, location, etc.) and then allows for partial 
matching based on a scoring and evaluation of context. 
Post-filtering has been applied to help recognise valid 
matches in order to improve precision by using statistical 
techniques such as the maximum entropy model [6] and 
term occurrence associated with candidate gene 
identifiers [12], or by employing machine learning (ML) 
techniques. ML techniques, in particular, may be 
difficult to develop as they need to rely on significant 
training data that would need to be generated for 
individual entries. [13] 
 
The problems with gene name identification are well 
recognised in the text mining community, and several 
state-of-the art evaluations have been organised so far 
(e.g. BioCreAtIvE 1 and 2 [10, 14]). The variability of 
gene name usage is still enormous and there are several 
pending problems and difficult cases in linking mentions 
with database entries as identified by the BioCreAtIvE 
outcomes. For example, mentions that refer to multiple 
genes (e.g. gene families, enumerations, conjoined or 
range expressions of gene names, etc.) need additional 
work to map them to the corresponding entries. Although 
addressed by several researchers [11], recognition and 
mapping of gene mentions that contain definitions of 
acronyms or gene symbols remains a challenge. The last 
BioCreAtIvE exercise also shows that difficult cases 
include permutations of gene names found in the lexicon.  
Finally, despite using different dictionaries and various 
spelling variation rules, there has been little discussion 
on their effect on precision and recall on a larger-scale 
task. Most of these issues are addressed in this paper. 
 
We present a generic and effective cascaded method to 
match gene and protein mentions with unique identifiers 
by using a combination of exact and approximate 
matching between the mentions and dictionary entries. A 
gene name dictionary has been automatically re-
engineered to support flexible matching, and a similar 
strategy (including morphological rules and linking 
orthographic variants) has been applied to gene mentions 
found in the literature. We differ from previous work by 
providing a canonical representation of gene synonyms 
and candidate gene mentions (from text), which are then 
compared in a cascade of different approaches, where 
more accurate steps are applied first. We also address 
multi-gene mentions (such as enumeration of gene 
names) and mentions that include text in parentheses. 
Finally, we systematically evaluate the effects of each 
step on precision and recall, and point to the main issues 
that still need to be solved. 
 
Methodology: 
Our gene name normalisation method works in several 
phases. The first phase is concerned with an automated 
creation and re-engineering of an extensive gene 
synonym dictionary. The second phase involves 
transformation and normalisation of gene mentions 
found in text. The following stage is related to exact 
matching, essentially based on a dictionary look-up 
which associates the gene mentions with the 
corresponding identifiers by using the gene synonyms 
dictionary generated in the first phase. Still, a simple 
lexicon look-up is often not sufficient to tackle highly 
variable and ambiguous gene mentions, especially for 
longer terms. Therefore, approximate matching uses a 
multi-stage procedure that includes, among others, 
permutation of components in gene names, and an 
approximate search in which a candidate synonym is 
allowed to contain one more component than a given 
mention. The major steps are explained below. 
 
Automated generation of synonym dictionaries 
Construction of lexical resources such as synonym 
dictionaries is a crucial step for a gene name 
normalisation system, as its quality and completeness 
affects the system performance. Dictionaries used in our 
system have been built fully automatically from two 
large, public, general genomic databases, Entrez Gene [3] 
and UniProt [4]. We have chosen the Entrez Gene 
database as a primary source, while UniProt has been 
used as a subsidiary one to enrich the content of the 
synonyms dictionary. Each entry in the synonym 
dictionary constructed consists of an Entrez Gene unique 
identifier and official symbol, along with a set of 
corresponding synonyms containing gene symbols and 
protein synonyms and aliases. 
 
There are numerous ambiguous gene names, associated 
with multiple gene identifiers either from an inter-
organism or from an intra-organism perspective. [15] 
Several systems have pruned their lexicons by moving 
ambiguous synonyms into a separate dictionary. [11] To 
avoid an extensive pruning of terms from the main 
dictionary, in cases where an official name was 
homonymous with another gene or protein synonym, we 
have kept only the official one in the corresponding 
entry, and moved the ambiguous aliases to a separate 
dictionary. 
 
One of the main reasons why the recognition of gene or 
protein names in text is not trivial is that there are often 
variations in spelling (e.g. ‘IL-1’, ‘IL I’). Still, there is a 
fair amount of structure, regularity or common “patterns” 
in naming variations in genomic databases, which can 
give clues for reengineering these databases into a form 
that is more appropriate for text mining. In order to 
generate a suitable form of the dictionary, we have 
implemented a number of generic re-engineering rules 
that are geared towards representing gene names as 
regular expression patterns rather than strings. These 
rules are applied to normalise synonyms in the dictionary 
in order to resolve the problem of orthographic variants. 
The synonym normalisation procedure consists of the 
following main steps applied in the given sequence: 
 
Organism prefix 
Gene names appearing in the dictionary can begin with 
an organism prefix (e.g. ‘h’ or ‘hum’ for human; ‘p’ for 
yeast). For such gene names, this prefix has been made 
optional i.e. an additional gene name without organism 
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indicator could be created, and added into the 
corresponding entry as a synonym.  
 
Punctuation symbols 
In general, strings contained within parentheses can be 
removed i.e. considered optional to form an alternative 
name (e.g. ‘CD44 molecule’ is considered as a variant of 
‘CD44 molecule (Indian blood group)’). There are some 
exceptions in which only the parentheses symbols are 
replaced by “white space” and strings within them are 
kept. These are: (1) if the string is a single character, and 
(2) if the parenthesized string consists of a combination 
of ‘+’ and a digit, single letter, Greek letter, or chemical 
symbols. All other punctuation symbols are replaced 
with optional “white space”. 
 
Digits, Greek letters, Roman numbers and single 
letters 
If a name contains digits, an additional synonym is made 
by separating the numerals from the rest of the name 
(e.g. ‘RP13-16H11.4’ generates ‘RP 13 16 H 11.4’). 
Similarly, Greek letters appearing at the beginning or at 
the end are separated from names using a set of simple 
rules (e.g. ‘Rev-ErbAalpha’ gives ‘Rev ErbA alpha’). A 
similar approach is undertaken for potential Roman 
numbers, taking into account the case of characters 
surrounding them (e.g. ‘Rh VI’ will be generated from 
‘RhVI’, while ‘ST3GALVI’ will not produce an 
additional entry ‘ST 3 GAL VI’). Finally, in some cases, 
single letters that start or end a gene name are also 
detached from it. More precisely, two cases are 
considered: if a word begins with a lower-case letter 
followed by a capital letter, and if the last letter differs in 
case from the preceding letter (e.g. ‘bTrCP’ will generate  
‘b TrCP’; ‘CoA’ will give ‘Co A’). 
 
The application of the above rules has resulted in an 
alternative representation of the dictionary that contains 
spelling variations represented as a set of canonical 
representatives. For example, name ‘alphaCP-4 protein’ 
is represented as ‘alpha_ε_CP_ε_4_protein’ where ‘_ε_’ 
denotes optional “white space” or separator. Obviously, 
canonical representatives may have resulted in some 
semantic distortion or ambiguity, which could impair 
precision. A simple way to limit this potential impact is 
to keep both the original and normalised forms of a 
synonym in the dictionary, but use the original forms 
first whenever possible. As a result, our dictionary 
contains two lists: the original synonyms list and the 
normalised canonical synonyms list. 
 
Pre-processing gene mentions 
Given a gene or protein mention in a document, we first 
apply a multiple-step mention pre-processing, which 
initially involves reducing plural forms to singular and 
identifying organism prefixes if any (as described for the 
dictionaries). However, unlike the parentheses “removal” 
approach used for dictionaries, we treat parentheses as a 
potential source of an alternative gene mention name that 
could be used for matching against the dictionary. For 
example, from candidate gene mention ‘interleukin (IL)-
17E’ we may consider two possible candidates for 
matching: ‘interleukin -17E’ and ‘IL-17E’. A context-
driven rule is used to generate alternative mention 
strings. More precisely, if a token that follows the right 
parenthesis is a digit, Roman number, Greek or single 
letter, or an “activity” descriptor (e.g. receptor, 
transporter, activator), then the token is concatenated to 
the text fragment extracted from the parentheses and 
used as a candidate mention referred to as the inside 
candidate, while a candidate obtained by deleting the text 
within parentheses is referred to as the outside candidate.  
 
Note that pre-processing can generate more than one 
candidate gene name mention from an original mention. 
All generated candidates will be used for matching, with 
priority-based filtering used in conflicting cases (see 
below for details).  
 
At this stage we also treat potential multi-gene name 
mentions, represented by enumerations and/or 
coordination of gene names (e.g. ‘ZNF133, 136’; ‘ORP 3 
to 6’). For each multi-gene type, rules have been written 
to handle it based on different contextual conditions. 
Table 1 presents examples of different context types. 
Note that the type of conjunctive coordinations or 
punctuation (‘/’ or ‘-‘) affects the generated candidate 
gene names (‘ORP 3 to 6’ would be transformed into 
four candidate terms, i.e. ‘ORP 3’, ‘ORP 4’, ‘ORP 5’ and 
‘ORP 6’, whereas ‘ORP 3/6’ only into two candidates: 
‘ORP 3’ and ‘OPR 6’). 
 
Following pre-processing, the same name normalisation 
steps described for dictionaries are applied to each 
candidate mention. This consequently results in two lists 
of gene mentions, one with original mentions, and one 
with alternative representations, which will be used for 
exact matching against the corresponding canonical 
dictionary entries (see below). 
 
We also generate an additional gene mentions list, which 
contains gene candidate mentions produced by using a 
set of token-based transformations. More precisely, each 
gene name is first lexically analysed, and split into a set 
of constituents. Each constituent is assigned with a token 
class (type). A set of token classes includes Digit, 
Single-Letter, Greek-Letter, Roman-Number, Chemical-
Element, Chemical-Name, Stop-Word, Non-Descriptive, 
UpperCase-Single-Word, etc. Elements of some classes 
are pre-collected from external resources (e.g. Stop-
Word from NCBI PubMed [16], and two chemical lists 
from the UMLS lexicon [17]). Non-Descriptive tokens 
represent biological terms that do not have significant 
impact on gene name matching (the token list has been 
obtained from the ProMiner project [18]). Other words 
that do not fall in any of the previous categories are 
tagged as Common-Word tokens.  
 
A number of token-based transformation rules are then 
applied to map semantically equivalent or related tokens 
in order to build a set of candidate forms. For example, 
similarly to previous work (e.g. [11]), Roman-Number 
tokens are replaced with equivalent Digit tokens, and 
Greek-Letter tokens with corresponding Single-Letter 
tokens, etc. Tokens that are potential well-known 
acronyms appearing within candidate gene names are 
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expanded with their long forms. [11] However, at this 
stage, we rely only on a list of the most frequent 
acronym-long form pairs, which has been precompiled 
from the original gene name dictionary. Finally, if two 
distinct Single-Letter tokens appear in a gene name 
mention and they are adjacent to each other, then these 
two tokens are merged (e.g., mention IL 2 R a also 
generates IL 2 Ra). 
 
The token-based transformations rules are applied 
iteratively until no new forms are generated. As a result, 
each candidate mention is associated with a set of 
additional transformed forms that will be used for exact-
like matching. Obviously, the gene name transformations 
extend the range of potential mentions, and thus could 
potentially improve recall. 
 
After the gene mentions are pre-processed and potential 
alternative forms generated, we apply a two-stage 
approach to map them against the gene dictionary. 
 
Stage 1: Exact Matching 
This first stage combines exact matching between 
original and normalised dictionary lists and the pre-
processed gene mentions lists. It is performed as a three-
step cascaded matching procedure that involves different 
dictionaries, as any still unmatched entries from the 
mentions list are carried forward to the next step: 
 
Step 1: Exact matching between original gene name 
mentions and the original synonym list; the resulting 
pairs are stored in E_Org list. 
Step 2: Exact matching between normalised unmatched 
gene name mentions and the normalised synonym list; 
the resulting pairs are stored in E_Norm list. 
Step 3: Using still unmatched gene mentions, perform 
exact matching between their corresponding token-based 
forms and the normalised synonym list; the resulting 
pairs are stored in E_Norm_T list. 
 
After each step (apart from Step 1), we consider matches 
that originated from the same mention (e.g. matches with 
and without organism prefix removed from the same 
mention). In cases of several matches for the same 
mention, priority-based filtering is applied. More 
precisely, in cases of matches that originated from an 
organism prefix and/or parentheses removal, we assign 
different priorities that reflect their importance in gene 
identifier recognition. For example, for the mention 
‘interleukin (IL)-17E’, the full-name i.e. the outside form 
‘interleukin-17E’ would have a higher priority than the 
“parenthesized” (inside) form ‘IL-17E’. Similarly, in 
case of a gene mention that includes an organism prefix, 
matching the original mention is put ahead of a potential 
match of the generated mention without the organism 
prefix. If there are no priorities to rely on, a majority 
matching is selected, and in cases where this is not 
possible, the candidate is passed to the subsequent step.  
 
Stage 2: Approximate Matching 
Exact matching typically fails in handling two types of 
cases: components permutations (i.e. components 
contained in a gene mention do not appear in the same 
order as in its assumed matched synonym), and missing 
words (i.e. certain words are missing from either gene 
mentions or synonyms). Approximate matching is thus 
necessary to help identify potential synonyms that are 
likely to match mentions that have not been recognised 
in the first stage.  
 
Similar to work described in [6, 9, 11, 19], our 
approximate matching approach is a token-class, i.e. 
components-based, method. These approaches usually 
utilise some weighting schema, where weights have been 
estimated from a training data. As our approach aims to 
be easily adaptable for different species, we used a 
simpler method with “binary” weights: only classes 
specific for gene names (namely Digit, Single-Letter, 
Greek-Letter, Roman-Number, and Chemical tokens) are 
considered (equally) important for the matching process.   
 
For the purpose of token-based approximate matching, 
tokenisation is first applied to both normalised mentions 
from text and normalised synonyms from the dictionary. 
We then carry out a two-step approximate matching 
approach. 
 
In the first step we consider potential component 
permutations and components missing from a candidate 
dictionary entry. In case of permutation, two terms are 
treated as equivalent if their tokens match regardless of 
the order in which they appear (e.g. ‘angiotensin II type 
1 receptor’ and ‘angiotensin II receptor type 1’). The 
resulting set of matches is denoted A_Perm. In case of 
components missing from a candidate dictionary entry, 
non-specific tokens (Stop-Word and Non-Descriptive) 
are initially discarded from both the gene mention name 
and candidate dictionary entry. If the terms consequently 
have the same tokens, they are regarded as positive 
matches, which are denoted as A_NonSpec. 
 
In the second step we consider cases where a potential 
dictionary entry contains one more token than a 
candidate mention. If the extra token belongs to a gene-
specific class, the candidate synonym has to be discarded. 
More precisely, if a candidate dictionary entry contains 
all tokens of a gene mention (specific or non-specific) 
and an extra non-specific token, then this pair is accepted 
as matching (e.g. ‘cytochrome c somatic’ and 
‘cytochrome c’). The matching pairs resulting from this 
sub-step are denoted as A_Extra1. Further, if a candidate 
dictionary entry matches all the specific tokens of a 
mention, and the only surplus token does not belong to 
any specific token class, then the pair is added to a 
matching list called A_Extra2. 
 
The overall two-stage matching approach is depicted in 
Figure 1. 
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Figure 1: The main steps in the matching process 
 
Experiments and Results: 
The experiments were conducted on the BioCreAtIve2 
data. BioCreAtIvE (Critical Assessment of Information 
Extraction systems in Biology) is a community-wide 
exercise in evaluation of text mining and information 
extraction systems applied to solve specific tasks in the 
biological domain, including identification of gene name 
mentions and their normalisation, extraction of protein-
protein interactions, protein function annotation etc. [8, 
14]  
 
For our experiments we used the BioCreAtIvE2 test and 
training data prepared for the human gene name 
normalisation (GN) task (see Table 2 in supplementary 
material for statistical information), in which gene name 
mentions have been previously marked. Our aim was to 
assess systematically the performance achieved by 
applying different matching approaches presented in this 
paper. We evaluated performance of the individual steps 
in the matching process on two different data sets which 
have been released for the GN task, as well as for their 
union. These two sets correspond to training (set-1) and 
testing (set-2) data for the BioCreAtIvE2 task. As our 
approach is rule-based, we have not used any of the sets 
for training, but for evaluation only. We report the 
results for each to allow for comparisons with other 
approaches and some discussions (since these two data 
collections may have slightly different distributions). We 
used standard evaluation metrics, namely recall, 
precision and F-measure shown in equation (1) (in 
supplementary material). 
 
As described previously, to support the task we have re-
engineered a synonym dictionary from the Entrez Gene 
database (see Table 3 in supplementary material for 
statistics). Adding additional entries from UniProt 
resulted in a 15.12% increase in the number of synonyms. 
Note also that the number of distinct normalised 
synonyms is smaller than the total number of distinct 
terms. The reason for this is that the normalisation 
process reduced some orthographic variation, so distinct 
gene names may have been mapped to the same 
normalised canonical form (e.g. both ‘IL-1A’ and ‘IL1A’ 
are normalised as ‘IL_ε_1_ε_A’). 
 
In the following subsections we describe the results for 
each of the processing stages and steps (see Figure 2 for 
a reminder of the matching lists generated in each step).
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Figure 2: The overall approach and the matching lists in the gene name normalisation system 
 
Evaluation of stage1: exact matching 
Table 4 (see supplementary material) presents the results 
from the three exact matching steps. Around half of gene 
mentions in the two data sets can be easily and directly 
mapped into entries in the dictionary without any 
complex processing (E_Org list). Adding successfully 
matched normalised mentions (E_Norm list) has resulted 
in a significant improvement in recall (more than 10% of 
the total number of gene mentions). Among the specific 
approaches, organism prefixes were the most accurate, 
while canonical normalisation of gene mentions brought 
most additional matches with very high precision (98%) 
proving that it can be an effective method to reduce the 
effects of orthographic variants in gene name mapping.  
 
As expected, processing multi-gene mentions did not 
perform as well, with precision ranging from 60% to 
77% (overall 64%). One of the reasons might be the 
construction of the BioCreAtIvE2 gold standard that we 
have used for evaluation – for example, although we 
correctly parsed gene enumerated mention ‘ZNF 133, 
136 and 140’ as referring to three candidates (‘ZNF 133’, 
‘ZNF 136’ and ‘ZNF 140’), the gold standard provided 
mapping for ‘ZNF 140’ only (so ‘ZNF 133’ and ‘ZNF 
136’ were treated as false positives).  
 
Generating candidates from mentions that contain 
parentheses proved to be useful for recall only to some 
extent. The precision of matches obtained from ignoring 
strings within parentheses (“outside” candidates) was 
high (cf. Table 4, parentheses removal), while it was 
unexpectedly low for candidates generated from the 
strings inside parentheses: we had 4 true positives and 8 
false matches, giving the precision of 33% (data not 
shown). One possible explanation is that we have not 
used any sophisticated acronym resolution at this point to 
check if the string inside parentheses matches the context 
(e.g. ‘ubiquitin-activating enzyme (E1)’). As generating 
new mentions from inside strings did not work well, it 
was not included in the final selection of normalisation 
steps. 
 
The third exact matching step (E_Norm_T, using token-
based transformations) resulted in encouraging results, 
with precision of 84% on average. The high precision 
performance proved that it can be a feasible way to 
improve opportunities of synonym matches by 
employing rules to produce more potential extended 
mentions with orthographic variants. It is interesting that 
these variants have not introduced many false positives 
as we have expected. 
 
At the end of the exact matching stage, our system 
performed reasonably well (see Table 5 given under 
supplementary material), achieving overall F-measure of 
76.36% (72.41% on set-1 and 79.71% on set-2), with 
precision of 95.68% and recall of 63.50%. 
 
Evaluation of stage 2: approximate matching 
The approximate matching stage resulted in four 
matching lists: A_Perm, A_NonSpec, A_Extra1, 
A_Extra2, and the corresponding results are presented in 
Table 6 (supplementary material). Overall, the token-
based approximate matching resulted in recall 
improvement of 5.53% (7.34% on set-1 and 3.90% on 
set-2), while precision was in the range of 70%. 
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The permutation-based matching (A_Perm) achieved an 
outstanding performance in precision (comparable to 
exact matching), showing that constituent order had no 
significant influence on matching accuracy in gene name 
normalisation. The largest improvement in recall was 
made in matching that disregarded one extra non-specific 
token in a candidate dictionary entry (A_Extra1), in 
which a total of 65 new correct matches were returned. 
This result suggests that more than 3% of gene mentions 
miss one or more words when compared with the 
corresponding dictionary entries. Still, the precision of 
this step is the lowest of all the approximate matching 
steps. 
 
Overall, the combined, two-staged cascaded approach 
(see Table 7 under supplementary material) achieved F-
measure of 79.25% (precision 93.05% and 69.02% 
recall). Slightly better performance was achieved on set-
2 (which is the BioCreAtIve2 test collection): F-measure 
of 81.20% (precision of 93.59% and recall of 71.72%), 
which is slightly better than the best performing system 
(F-measure of 81.1%) in the BioCreAtIve2 challenge. 
 
Discussion: 
We have analysed the effects of different matching 
approaches on performance. While exact and exact-like 
approaches (namely A_Norm, E_Norm, E_Norm_T, 
A_Perm) seem to be highly accurate and consistent in 
two data collections (set-1 and set-2), the performance of 
token-based approximate matching varied significantly. 
For example, A_Exact1 (ignore one extra non-specific 
token in a candidate dictionary entry) performed 
reasonably well on set-1 data, but the precision has 
decreased by almost 20% on set-2. One possible 
explanation for this is different distributions of the types 
of matching cases in the two data sets, which has been 
noted by the BioCreAtIvE participants.  
 
Although generic, the gene mention normalisation 
approach proved to be useful and accurate, improving 
the overall recall by more than 7%, with precision of 
97% (see Table 4, RN row). In cases where multiple 
normalised candidate mentions have been generated for a 
single mention, in almost two thirds of cases all the 
generated candidates mapped to the same ID. This 
suggests that there are some common “patterns” or 
regularity in gene name variations that appear in the 
literature. In case of ambiguity (where several candidates 
for the same mention refer to different database entries), 
one of the approaches that we plan to employ is to do 
context-based post filtering by prioritising the mentions 
that occur elsewhere within an abstract over other 
candidates that have never occurred in the same 
document. This approach could be specifically useful for 
gene symbols, as Schuemie [20] reported that 30% of 
gene symbols in abstracts were accompanied by full 
names, and this document-wide distribution could help in 
gene identification. 
 
When compared to other approaches that are based on 
exact matching using gene name dictionaries, our 
approach has better precision (93.59% compared to up to 
84% of ProMiner [11, 18] on the same set-2 data) but 
lower recall (71.72% compared to 73-80%), suggesting 
that our rules for re-engineering the gene name 
dictionary were more restrictive and have not resulted in 
significant semantic distortion of normalised synonyms. 
This would also mean that the dictionary is geared for 
high precision applications. 
 
Using normalised and transformed forms of gene 
mentions improved exact-match recall by almost 14%, 
while reducing the precision by only 2%. On the other 
hand, applying approximate matching improved recall by 
5.53% (7.34% on set-1), with significant drop in 
precision (more than 10%). Our analysis of the false 
positive matches in approximate matching showed that 
there are three main types of errors that contribute to an 
increase in mismatching. As illustrated in Table 8 
(supplementary material), the first category of errors 
corresponds to an extra word in a detected synonym that 
is an important component (such as receptor, protein or 
kinase). The second error type is related to surplus words 
contained in mismatched synonyms that belong to 
abbreviations of full-name gene mentions.  
 
The third type of errors is related to ambiguous terms 
that have been removed from the synonym list. 
Obviously, the system would need to assign an 
approximate match in these cases as well. There are three 
possible solutions to improve precision in this case: (a) 
Identify important terms from the synonym list, which 
could not be missed in a gene mention when performing 
matching. (b) If an extra word in a detected synonym is 
composed of uppercase letters, filter out the match in the 
matching list. (c) The ambiguous synonym lists created 
during the dictionary re-engineering is used in gene 
name normalisation by a general disambiguation 
approach, e.g. based on machine learning. 
 
While component permutations seem not to be important 
in matching, ignoring one extra non-specific constituent 
provided quite a few false positives (precision of 63%) 
as well as quite a few true positives (improving recall by 
3%). This means that our notion of specific components 
was too vague, and would need to be reconsidered if a 
better precision is needed for a given task.  
 
We have experimented with “switching” on and off some 
steps in the cascade, and analysed their effect on 
performance in order to identify “optimal sequences” for 
improving precision or recall. The main conclusion of 
this exercise is that each step resulted in an overall 
improvement of F-measure (so, an optimal cascade with 
regard to F-measure would contain all steps), while some 
of the steps positively improved precision and some 
recall. For example, much higher precision (96.60% 
compared to 93.05%) could be achieved by switching off 
the steps that relate to treating enumerations and ignoring 
one extra non-specific component, with overall drop in 
F-measure of only less than 1.5%.  
 
A possibility to switch particular steps on and off could 
be used to “control” performance trade-offs between 
precision and recall to suit specific applications. For 
example, if gene name identification is used to support a 
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curation task (e.g. description of gene regulatory 
networks) then the cascade can be geared for a higher 
precision by eliminating the steps that introduce a 
number of false positives. On the other hand, if gene 
identification is part of a hypothesis generation task that 
uses text-based features, then the user may put more 
emphasis on recall and select the steps that bring in more 
true positives. Similarly, if an application is involved in 
mining relations between genes, then multi-gene 
mentions would be an important step to incorporate. 
 
Conclusions: 
Mapping gene and protein mentions identified in 
biological text to referent genomic databases remains an 
essential and challenging task due to lexical and 
morphological variation, and ambiguities in the existing 
gene nomenclature. The goal of our work is to explore 
the potential in using an extended synonyms dictionary 
combined with a number of matching approaches to 
enhance the performance of gene name normalisation. 
The experiments have shown that only a half of gene 
mentions could be mapped using a direct dictionary 
lookup. Therefore, in this paper we have described an 
automated generation of a synonym dictionary that is 
suitable for accurate matching of gene and protein 
names. A multiple-step mention pre-processing method 
has been proposed to resolve morphological variation 
and provide alternative “readings” of gene mentions, 
along with two gene name matching approaches. These 
approaches have shown a positive impact on matching 
performance, in particular exact-like matching which 
improves recall by 14% with only 2% reduction in 
precision. Ignoring component ordering within a gene 
mention proved to be an accurate approach. The results 
presented in our experiments demonstrated that each step 
resulted in improvement in either precision or recall, or 
both. Together, the two stages achieved an F-measure of 
81.20% at 93.59% precision and 71.72% recall on the 
BioCreAtIve2 test collection, improving the best 
performing results in the field.  
 
The proposed approach is generic and the procedures and 
rules introduced are not specific to any species (the only 
module that would need “customisation” is treating 
organism prefixes). The experiments have shown that 
this simple and generic approach can be used to 
efficiently normalise gene name mentions, and can be 
customised to suit improvement in precision or recall 
depending on the task that follows gene name 
normalisation. 
 
Still, we view this work as a first step, with a number of 
interesting problems remaining open for further research. 
First, we intend to investigate ways to develop more 
effective matching algorithms, and provide an efficient 
Web service to the community that would normalise 
gene mentions in Medline abstracts. In addition, as 
mentioned previously, an abbreviation dictionary in 
transformation of gene mentions could be used to 
improve precision. We already have an acronym 
detection module that will be integrated in the matching 
process. Further, it will be necessary to consider 
potential ambiguous synonyms when matching using a 
wider context (e.g. abstract). 
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Supplementary material 
 
FNTP
TPR +=          FPTP
TPP +=         RP
PRmeasureF +=−
2
 
(1) 
 
TP (true positive) is the number of correctly matched gene names, FN (false negative) is the number of genes not 
mapped by the system, and FP (false positive) the number of genes that are incorrectly normalised.  
 
Tables: 
 
Multiple gene name mention Involved gene names 
creatine kinase M and B 
M and B creatine kinase 
ZNF133, 136 and 140 
Cofactors A, D, E 
AKR1C1-AKR1C4 
Hmad-3/4 
ORP-3 to 6 
creatine kinase M; creatine kinase B 
M creatine kinase; B creatine kinase 
ZNF133; ZNF136; ZNF140 
Cofactors A; Cofactors D; Cofactors E 
AKR1C1; AKR1C2; AKR1C3; AKR1C4 
Hmad-3; Hmad-4 
ORP-3; ORP-4; ORP-5; OPR-6 
Table 1: Multiple gene mentions examples 
 
 # abstracts # gene mentions # matched gene identifiers 
Set-1 (“training” data) 
Set-2 (“test” data) 
281 
262 
985 
1092 
995 
1100 
Set-0 (total) 543 2077 2095 
Table 2: The BioCreAtIve2 GN data collections 
 
 # Entrez 
terms 
# combined 
terms 
# distinct 
terms 
#distinct  
normalised terms 
NCBI Gene ID 
Gene Symbol 
Protein Name 
Synonym per ID 
Ambiguous synonym 
146,022 
206,514 
182,625 
2.66 
– 
146,022 
212,404 
235,577 
3.06 
– 
146,022 
195,028 
191,711 
2.65 
61,242 (13.68%) 
146,022 
193,211 
188,468 
2.61 
66,302 (14.81%) 
Table 3: Synonym dictionary statistics 
 
Set-1 Set-2 Set-0  
TP FP P R TP FP P R TP FP P R 
E_Org 441 11 0.97 0.443 603 13 0.98 0.548 1044 24 0.97 0.498 
OP 10 0 1.00 0.01 18 0 1.00 0.016 28 0 1.00 0.013 
PR 7 0 1.00 0.07 7 1 0.87 0.006 14 1 0.93 0.007 
MG 24 16 0.60 0.024 17 7 0.77 0.015 41 23 0.64 0.019 
RN 74 3 0.96 0.074 82 1 0.99 0.075 156 4 0.97 0.074 
 
 
E_Norm 
Total* 115 19 0.85 0.115 124 9 0.93 0.113 239 28 0.90 0.114 
E_Norm_T 28 4 0.87 0.028 19 5 0.79 0.017 47 9 0.84 0.022 
Total Exact Macth 584 34 0.94 0.587 746 27 0.97 0.679 1330 61 0.96 0.635 
Table 4: Results of individual steps in exact matching. OP (organism prefix), PR (parenthesis removal), MG 
(multi-gene mentions), RN(Rule-based normalisation) 
 
 Set-1 Set-2 Set-0 
F-Measure 
Precision 
Recall 
72.42% 
94.50% 
58.69% 
79.71% 
96.80% 
67.90% 
76.36% 
95.68% 
63.50% 
Table 5: Matching accuracy for exact matching in the three data sets 
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Set-1 Set-2 Set-0  
TP FP P R TP FP P R TP FP P R 
A_Perm 14 1 0.93 0.014 9 0 1.00 0.008 23 1 0.96 0.01 
A_NonSpec 12 4 0.80 0.012 4 2 0.68 0.003 16 6 0.73 0.007 
A_Extra1 38 14 0.73 0.038 27 24 0.52 0.035 65 38 0.63 0.031 
A_Extra2 9 1 0.90 0.009 3 1 0.75 0.003 12 2 0.87 0.006 
Total approx. 
matching 73 20 0.78 0.073 43 27 0.61 0.039 116 47 0.71 0.055 
Table 6: Results of the individual steps in approximate matching 
 
 Set-1 Set-2 Set-0 
Total TP 
Total FP 
657 
 54 
789 
 54 
1446 
 108 
F-Measure 
Precision 
Recall 
77.02% 
92.40% 
66.03% 
81.20% 
93.59% 
71.72% 
79.25% 
93.05% 
69.02% 
Table 7: Overall matching accuracy for gene name normalisation in the three data sets 
 
Type of error Normalised mention example Mismatched synonym example 
Important biological word 
missed 
 
NK 3 
I kappa B alpha 
IL 1 ra 
NK 3 receptor 
I kappa B kinase alpha 
IL 1 ra homolog 
Abbreviation of full-name 
protein 
 
CRP 2 
Trx 
Protein kinase 2 
CRP 2 BP 
MT Trx 
SFRS protein kinase 2 
Ambiguity 
 
TR 1 
DGI 
Mada 
TR ALPHA 1 
DGI 1 
MADA 
Table 8: Examples of false positive matches in token-based approximate matching (the mismatched words are 
marked in italics) 
 
